Cargando…
Genome-wide identification of genetic determinants for the cytotoxicity of perifosine
Perifosine belongs to the class of alkylphospholipid analogues, which act primarily at the cell membrane, thereby targeting signal transduction pathways. In phase I/II clinical trials, perifosine has induced tumour regression and caused disease stabilisation in a variety of tumour types. The genetic...
Autores principales: | Zhang, Wei, Liu, Wanqing, Poradosu, Enrique, Ratain, Mark J |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3525180/ https://www.ncbi.nlm.nih.gov/pubmed/19129090 http://dx.doi.org/10.1186/1479-7364-3-1-53 |
Ejemplares similares
-
Synergistic cytotoxicity of perifosine and ABT‐737 to colon cancer cells
por: Adamová, Barbora, et al.
Publicado: (2022) -
Perifosine as a potential novel anti-telomerase therapy
por: Holohan, Brody, et al.
Publicado: (2015) -
Proteome and Acetylome Analysis Identifies Novel Pathways and Targets Regulated by Perifosine in Neuroblastoma
por: Gu, Xiao, et al.
Publicado: (2017) -
Phase I clinical trial of temsirolimus and perifosine for recurrent glioblastoma
por: Kaley, Thomas J., et al.
Publicado: (2020) -
Contribution of 3D genome topological domains to genetic risk of cancers: a genome-wide computational study
por: Jablonski, Kim Philipp, et al.
Publicado: (2022)